First Personal Financial Services’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$276 Buy
+1
New +$260 ﹤0.01% 433
2018
Q2
Sell
-326
Closed -$39K 657
2018
Q1
$39K Buy
326
+77
+31% +$9.93K 0.01% 484
2017
Q4
$32K Buy
249
+30
+14% +$3.77K 0.01% 549
2017
Q3
$26K Hold
219
0.01% 535
2017
Q2
$17K Hold
219
﹤0.01% 608
2017
Q1
$11K Hold
219
﹤0.01% 688
2016
Q4
$8K Buy
+219
New +$9.17K ﹤0.01% 747

Other funds holding ALNY

First Personal Financial Services's ALNY Position: Q3 2024 in Review

First Personal Financial Services opened a new position in Alnylam Pharmaceuticals (ALNY) in Q3 2024: 1 share worth $276. The stake represents ﹤0.01% of the portfolio and ranks #433 among its holdings. This is a return to the name: First Personal Financial Services previously reported a position in ALNY as recently as Q1 2018.

First Personal Financial Services first reported a position in ALNY in Q4 2016 and has held it in 7 quarters since. The position peaked at $39K in Q1 2018. 566 funds tracked by Wall St. Rank hold ALNY as of Q3 2024.

  • First Personal Financial Services held 1 share of Alnylam Pharmaceuticals worth $276 as of Q3 2024.
  • Alnylam Pharmaceuticals was a new First Personal Financial Services position in Q3 2024.
  • Alnylam Pharmaceuticals made up ﹤0.01% of First Personal Financial Services's portfolio in Q3 2024, its #433 holding.
  • First Personal Financial Services first reported a position in Alnylam Pharmaceuticals in Q4 2016 and has held it in 7 quarters since.
  • First Personal Financial Services's Alnylam Pharmaceuticals position peaked at $39K in Q1 2018.
  • 566 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q3 2024.

Based on First Personal Financial Services's 13F filing for Q3 2024, filed 1 Nov 2024.